Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2107)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (105)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (846)
  3. JNCI: Journal of the National Cancer Institute (485)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel dual histone 3 K27M and G34R point mutations in a midline glioma
    Meeting Abstract

    Pan, P.; Bale, T.; Miller, A.; Ladanyi, M.; Rosenblum, M.; Haggiagi, A.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of proton craniospinal irradiation for patients with leptomeningeal carcinomatosis
    Meeting Abstract

    Wijetunga, N. A.; Mohammed, N.; Yamada, Y.; Wolden, S.; Seidman, A.; Yu, H.; Kris, M.; Malani, R.; Pentsova, E.; Boire, A.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors: An expanded dataset
    Meeting Abstract

    Perreault, S.; Doz, F.; Drilon, A.; Geoerger, B.; Boni, V.; Chisholm, J.; Dubois, S. G.; Grilley-Olson, J. E.; Hong, D. S.; Italiano, A.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Decoding the immune system response to leptomeningeal metastasis
    Meeting Abstract

    Remsik, J.; Tong, X.; Sener, U.; Isakov, D.; Chi, Y.; Iacobuzio-Donahue, C.; Pe'er, D.; Schietinger, A.; Boire, A.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Neurologic assessment in neuro-oncology (NANO) scale in a phase II study of pembrolizumab or pembrolizumab plus bevacizumab in patients with recurrent glioblastoma
    Meeting Abstract

    Nayak, L.; Molinaro, A.; Peters, K.; Clarke, J.; Jordan, J.; de Groot, J.; Nghiemphu, P.; Kaley, T.; Colman, H.; McCluskey, C.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • A pilot study of germline coding mutations associated with impaired development and adaptive behavior in pediatric medulloblastoma patients treated on head start 4
    Meeting Abstract

    Sells, B.; Bell, E.; Fleming, J.; McElroy, J.; Webb, A.; Zhao, Y.; Graham, R.; Guo, Y.; Liu, T.; Timmers, C.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Debio1347, an oral FGFR inhibitor: Results from a single center study in pediatric patients with recurrent/refractory FGFR altered gliomas
    Meeting Abstract

    Sait, S. F.; Rosenblum, M.; Bale, T.; Haque, S.; Gilheeney, S.; Spatz, K.; Prince, D.; Ibanez, K.; Dunkel, I.; Karajannis, M.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed (ND) or recurrent/refractory (R/R) glioblastoma (GBM); Phase 1B/2 study update
    Meeting Abstract

    Piotrowski, A.; Puduvalli, V.; Wen, P.; Colman, H.; Campian, J.; Pearlman, M.; Butowski, N.; Cloughesy, T.; Battiste, J.; Glass, J.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of everolimus (Afinitor®) for children with recurrent or progressive ependymoma
    Meeting Abstract

    Bowers, D.; Karajannis, M.; Gardner, S.; Su, J.; Baxter, P.; Partap, S.; Klesse, L.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Pilot study of repeated planned glucarpidase following high dose methotrexate (HD-MTX) in CNS lymphoma (CNSL)
    Meeting Abstract

    Schaff, L.; Lobbous, M.; Sener, U.; Gavrilovic, I.; Miller, A.; Stone, J.; Piotrowski, A.; Skakodub, A.; Madzsar, J.; Schumpp, A.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save